LKFT: Lakefront Biotherapeutics N.V.
Performance
LKFT +6.31%
Watchlist
Select an item
Summary
LKFT at a glance
LKFT returned +6.31% over the past year and -9.17% a year over five years. Its worst drop in that year was -24.71%, smaller than 70% of stocks on Redstone, and its Sharpe ratio of 0.23 beats 37% of stocks on Redstone. It pays no dividends.
Current Drawdown
-3.23%
Rolling Volatility
27.01%
Actions
Metrics
Risk Indicators
Alpha-0.02%
Beta0.64x
Sharpe0.23
Sortino0.34
Omega1.04
Calmar0.26
Martin0.46
Profile
About LKFT
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need.
- Sector
- Health Care
- Market cap
- $2.2B
- Listed
- Dec 2008
- Employees
- 452
- Website
- lakefrontbio.com
Comparisons